Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Role of Neurotransmitters in Memory01:23

Role of Neurotransmitters in Memory

Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
 Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of Lewy body pathology and phenotypic associations in patients with mild cognitive impairment: Evidence from the Interceptor study.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

Non-Invasive Brain Stimulation in Frontotemporal Dementia: A Systematic Review of Non-Pharmacological Treatment Approaches.

International journal of molecular sciences·2026
Same author

Mild cognitive impairment-to-Alzheimer's dementia progression risk: the contribution of the Interceptor project.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Clinical utility and prospective of TMS-EEG: Updated review from an international expert group.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2026
Same author

Low intensity transcranial electric stimulation: Safety, ethical, legal regulatory and application guidelines (2017-2025: An update) - endorsed by the European Society for Brain Stimulation (ESBS) and by the International Federation for Clinical Neurophysiology (IFCN).

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2026
Same author

Plasma extracellular vesicles and phosphorylated tau 181 as early biomarkers of cognitive impairment in Alzheimer's dementia.

Alzheimer's research & therapy·2026
Same journal

The causal efficacy of consciousness: a neuroscientific analysis and explanation.

Frontiers in human neuroscience·2026
Same journal

Temporal-oscillatory entrainment: a multi-timescale framework for rhythmic coordination from neural to social frequencies.

Frontiers in human neuroscience·2026
Same journal

Role of AQP4 in ameliorating heat stress-induced cellular injury in a cell line model through active heat acclimation.

Frontiers in human neuroscience·2026
Same journal

Correction: Cognitive state monitoring for neuroadaptive information visualization.

Frontiers in human neuroscience·2026
Same journal

The synthetic self-hypothesis: dopaminergic redirection through self-face recognition in stuttering therapy.

Frontiers in human neuroscience·2026
Same journal

A randomised, placebo-controlled, triple-blind clinical trial to investigate the efficacy of <i>Ginkgo biloba</i> extract EGb 761<sup>®</sup> in cognitive impairment associated with post COVID-19 syndrome-the EGb COCOS protocol.

Frontiers in human neuroscience·2026
See all related articles

Related Experiment Video

Updated: May 24, 2026

Transcranial Direct Current Stimulation (tDCS) for Memory Enhancement
10:37

Transcranial Direct Current Stimulation (tDCS) for Memory Enhancement

Published on: September 18, 2021

Non-pharmacological intervention for memory decline.

Maria Cotelli1, Rosa Manenti, Orazio Zanetti

  • 1IRCCS Centro San Giovanni di Dio Fatebenefratelli Brescia, Italy.

Frontiers in Human Neuroscience
|March 13, 2012
PubMed
Summary
This summary is machine-generated.

Non-pharmacological memory interventions show promise for older adults and those with brain damage. Cognitive rehabilitation and non-invasive brain stimulation may improve memory performance, but more research is needed.

Keywords:
AlzheimerMCIagingbrain stimulationtraining

More Related Videos

Orienteering as a Tool for Cognitive Research: An Implementation Guide
07:13

Orienteering as a Tool for Cognitive Research: An Implementation Guide

Published on: November 29, 2024

Related Experiment Videos

Last Updated: May 24, 2026

Transcranial Direct Current Stimulation (tDCS) for Memory Enhancement
10:37

Transcranial Direct Current Stimulation (tDCS) for Memory Enhancement

Published on: September 18, 2021

Orienteering as a Tool for Cognitive Research: An Implementation Guide
07:13

Orienteering as a Tool for Cognitive Research: An Implementation Guide

Published on: November 29, 2024

Area of Science:

  • Neuroscience
  • Gerontology
  • Cognitive Psychology

Background:

  • Growing interest in non-pharmacological memory interventions for healthy aging, brain damage, and neurodegenerative disorders.
  • Limited efficacy of current drug therapies and the brain's plasticity during aging drive research.
  • Non-invasive brain stimulation techniques show potential for enhancing cognitive performance in neurological conditions.

Purpose of the Study:

  • To review memory rehabilitation strategies for mild cognitive impairment and Alzheimer's disease.
  • To examine cognitive rehabilitation interventions focused on memory.
  • To explore the role of non-invasive brain stimulation in memory enhancement.

Main Methods:

  • Literature review of studies on memory rehabilitation.
  • Analysis of cognitive rehabilitation interventions for memory deficits.
  • Examination of non-invasive brain stimulation techniques (e.g., repetitive transcranial magnetic stimulation, transcranial direct current stimulation).

Main Results:

  • Memory intervention therapy may lead to performance improvements in individuals with memory deficits.
  • Non-invasive brain stimulation has shown enhanced cognitive performance in some neurological disease patients.
  • Evidence suggests potential benefits of memory rehabilitation approaches.

Conclusions:

  • Non-pharmacological memory interventions, including cognitive rehabilitation and non-invasive brain stimulation, offer potential for improving memory.
  • Further research is necessary to definitively establish the value and efficacy of these memory enhancement strategies.
  • Memory rehabilitation holds promise for individuals experiencing memory difficulties across various cognitive states.